Teva
Pharmaceutical Industries Ltd. (NYSE: TEVA) abandoned its hostile bid for Mylan (Nasdaq: MYL) and has
offered $40.5 billion in cash and stock to buy Allergan's (NYSE: AGN)
generic drug business. Shares of Teva surged $8.73 to $70.58 while Mylan stock plummeted $9.96 to $55.98. Allergan stock leaped $18.90 to $327.11.
Teva to buy Allergan's generic drug unit
July 27, 2015 at 14:58 PM EDT